Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma
Pancreatology · 2025
DOI: 10.1016/j.pan.2025.06.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2025. Verfasst von Takaaki Furukawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; Department of G…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Liquid biopsy offers an alternative to tissue specimens for comprehensive genomic profiling. However, detection of circulating tumor DNA (ctDNA) remains challenging in pancreatic ductal adenocarcinoma (PDAC). This study assessed predictive ability of CA19-9 and other factors for detecting KRAS mutations on liquid biopsy. METHODS: We retrospectively reviewed clinical and genomic databases for PDAC patients who underwent liquid biopsy between September 2021 and August 2024. RESULTS: A total of 106 patients were enrolled. The overall detection rate of KRAS mutations was 48 %. Univariate analysis identified hepatic metastases (Odds ratio (OR) 4.50, p 10 % compared to those with Max VAF
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for…
- Department of Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Zitieren
APA
Furukawa, T., Fukada, I., Hayashi, N., Okamoto, T., Sato, Y., Maegawa, Y., Hirai, T., Mie, T., Takeda, T., Sasaki, T., Ozaka, M., Takahashi, S., & Sasahira, N. (2025). Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma. Pancreatology. https://doi.org/10.1016/j.pan.2025.06.013
Vancouver
Furukawa T, Fukada I, Hayashi N, Okamoto T, Sato Y, Maegawa Y, et al. Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma. Pancreatology. 2025. doi:10.1016/j.pan.2025.06.013
BibTeX
@article{Furukawa2025,
author = {Furukawa, Takaaki and Fukada, Ippei and Hayashi, Naomi and Okamoto, Takeshi and Sato, Yoichiro and Maegawa, Yuri and Hirai, Tatsuki and Mie, Takafumi and Takeda, Tsuyoshi and Sasaki, Takashi and Ozaka, Masato and Takahashi, Shunji and Sasahira, Naoki},
title = {Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma},
journal = {Pancreatology},
year = {2025},
doi = {10.1016/j.pan.2025.06.013}
}
EUVIMED